METHODS: We conducted a prospective study of 103 critically ill patients who were periodically monitored with electromyography.
RESULTS: The development of AWCIP was observed in 63 patients. The group of patients who developed AWCIP had a significantly higher utilization of neuromuscular blocking agents than the group who did not develop AWCIP [79.4% vs 50%, OR:3.85 (1.63-9.39), p <0.02]; likewise, this group of patients had a longer ICU stay [32 days vs 14 days, OR: 1.11 (1.06-1.17), p <0. 001] and a longer mechanical ventilation time [24 days vs 9 days, OR:1.2 (1.11-1.32), p <0.001].
CONCLUSIONS: Neuromuscular blocking agents are a factor associated with the occurrence of AWCIP.
方法:我们对103例接受定期肌电图监测的危重患者进行了前瞻性研究。
结果:在63例患者中观察到AWCIP的发展。开发AWCIP的患者组的神经肌肉阻滞剂利用率明显高于未开发AWCIP的患者组[79.4%vs50%,OR:3.85(1.63-9.39),p<0.02];同样,这组患者的ICU住院时间较长[32天比14天,OR:1.11(1.06-1.17),p<0。001]和更长的机械通气时间[24天比9天,OR:1.2(1.11-1.32),p<0.001]。
结论:神经肌肉阻断剂是与AWCIP发生相关的因素。